Par Drugs and Chemicals Limited
NSE:PAR.NS
95.99 (INR) • At close July 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 133.579 | 145.01 | 150.792 | 127.032 | 147.261 | 59.919 | 32.837 | 25.53 | 31.833 | 4.218 |
| Depreciation & Amortization
| 36.466 | 34.361 | 32.332 | 32.812 | 28.194 | 27.615 | 30.37 | 31.358 | 28.2 | 26.496 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -53.651 | 20.034 | -4.634 | -54.256 | -3.387 | -8.546 | 3.043 | -29.543 | 14.488 | -4.178 |
| Accounts Receivables
| -29.999 | 32.365 | 14.983 | -60.158 | -0.831 | -38.486 | 2.049 | -6.121 | -7.358 | 1.399 |
| Inventory
| -19.289 | 12.019 | -6.662 | -17.16 | -0.799 | 13.773 | -2.266 | -0.787 | 15.9 | -16.039 |
| Accounts Payables
| 0 | 0 | -25.702 | 39.44 | 5.133 | 12.727 | -3.295 | -25.218 | 13.477 | 0 |
| Other Working Capital
| -4.363 | -24.35 | 12.747 | -16.378 | -6.89 | 3.44 | 6.556 | -28.756 | -1.412 | 10.462 |
| Other Non Cash Items
| 45.208 | 3.084 | -44.719 | -29.436 | -51.218 | -2.076 | 9.522 | 15.838 | 17.203 | 38.738 |
| Operating Cash Flow
| 161.602 | 202.489 | 133.771 | 76.152 | 120.851 | 76.912 | 75.772 | 43.183 | 91.724 | 65.274 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -12.266 | -60.803 | -76.336 | -32.023 | -50.491 | -15.587 | -3.43 | -6.389 | -18.099 | -1.528 |
| Acquisitions Net
| 0 | 0.12 | 2 | 0 | 49.206 | 0.25 | 0 | 0 | 0.75 | 0 |
| Purchases Of Investments
| -250.581 | -0.019 | 0 | 0 | -49.671 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0.465 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 10.477 | 2.321 | 0.955 | 1.839 | 50.998 | 0.765 | 0.887 | 0.401 | 1.097 | -0.17 |
| Investing Cash Flow
| -252.37 | -58.381 | -73.381 | -30.184 | 0.507 | -14.572 | -2.543 | -5.988 | -17.002 | -1.698 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | -76.396 | 30.206 | -57.314 | -73.266 | -14.9 | -59.413 | -50.905 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 85.272 | 60 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | -15.381 | -7.69 | -9.271 | -0.001 | -0.001 | -0.001 | -0.001 |
| Other Financing Activities
| 0 | 0 | -0.024 | -3.723 | -6.027 | -9.122 | -18.115 | -25.149 | -24.418 | -3.694 |
| Financing Cash Flow
| 0 | 0 | -0.024 | -95.542 | 16.489 | 11.146 | -73.56 | -36.741 | -83.832 | -54.6 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | -0 | 0 | -0.001 | 0 | -0.001 | 0.319 |
| Net Change In Cash
| -90.767 | 144.109 | 60.366 | -49.574 | 137.847 | 73.486 | -0.332 | 0.454 | -9.111 | 9.295 |
| Cash At End Of Period
| 275.772 | 366.539 | 222.43 | 162.064 | 211.638 | 73.792 | 0.306 | 0.638 | 0.184 | 9.295 |